Stefan Sperl
Directeur des opérations chez KIORA PHARMACEUTICALS, INC.
Postes actifs de Stefan Sperl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Directeur des opérations | - | - |
Historique de carrière de Stefan Sperl
Anciens postes connus de Stefan Sperl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Directeur des opérations | 01/07/2013 | - |
| Fondateur | 01/07/2013 | - |
Formation de Stefan Sperl
| Max Planck Institute of Biochemistry | Doctorate Degree |
Statistiques
Internationale
| Autriche | 3 |
| Etats-Unis | 2 |
| Allemagne | 2 |
Opérationnelle
| Chief Operating Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Bourse
- Insiders
- Stefan Sperl
- Expérience
